Emergence of Pseudomonas aeruginosa cross-infection in children with cystic fibrosis attending an Iranian referral pediatric center

Iranian Journal of Microbiology

Volumn 4, Issue 3, 2012, Pages 124-129

  Goudarzi, Hossein ^a   Ghazi, M ^a   Khanbabaee, G ^a   Fallah, F ^a   Kazemi, B ^b   Mahmoudi, S ^c   Navidnia, M ^a   Pourakbari, B ^c   Bakhshi, B ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Cystic fibrosis; Genotyping; Iran; P. aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CROSS INFECTION; CYSTIC FIBROSIS; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS POLYMERASE CHAIN REACTION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; MALE; NONHUMAN; PEDIATRIC HOSPITAL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD;

ENTEROBACTERIACEAE; PSEUDOMONAS AERUGINOSA;

EID: 84870316981     PISSN: 20083289     EISSN: 20084447     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mir TA, Ashraf M, Ahmed K, Chowdhary J, Rehana B, Ahmed J. Clinical profile, diagnostic delay, and genetic make-up of cystic fibrosis in Kashmir, India. Lung India 2011; 28: 97-100.
2. Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005; 4 Suppl 2: 49-54.
3. Hoiby N. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med 2011; 9: 32.
4. Bradbury RS, Champion AC, Reid DW. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital. J Hosp Infect 2009; 73: 151-156.
5. Hafiane A, Ravaoarinoro M. Various typing methods of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Med Mal Infect 2008; 38: 238-247.
6. Kidd TJ, Grimwood K, Ramsay KA, Rainey PB, Bell SC. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Clin Microbiol 2011; 49: 263-268.
7. Stehling EG, Leite DS, Silveira WD. Molecular typing and biological characteristics of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Brazil. Braz J Infect Dis 2010; 14: 462-467.
8. (NCCLS) National Committee for Clinical Laboratory Standards. (2004). Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement M100-S14. National Committee for Clinical Laboratory Standards, Wayne, Pa
9. Syrmis MW, O'Carroll MR, Sloots TP, Coulter C, Wainwright CE, Bell SC, et al. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitiveelement-based PCR assays. J Med Microbiol 2004; 53: 1089-1096.
10. Bradbury RS, Tristram SG, Roddam LF, Reid DW, Inglis TJ, Champion AC. Antimicrobial susceptibility testing of cystic fibrosis and non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa: a comparison of three methods. Br J Biomed Sci 2011; 68: 1-4.
11. Tramper-Stranders GA, van der Ent CK, Wolfs TF, Kimpen JL, Fleer A, Johansen U, et al. Pseudomonas aeruginosa diversity in distinct paediatric patient groups. Clin Microbiol Infect 2008; 14: 935-941.
12. Cramer N, Wiehlmann L, Tummler B. Clonal epidemio- logy of Pseudomonas aeruginosa in cystic fibrosis. Int J Med Microbiol 2010; 300: 526-533.
13. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35: S65-164.
14. O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, Coulter C, et al. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004; 24: 101-106.
15. Jakobsson BM, Onnered AB, Hjelte L, Nyström B. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients. J Hosp Infect 1997; 36: 201-207.
16. Wolf MF, Simon A. The use of piperacillin-tazobactam in neonatal and paediatric patients. Expert Opin Drug Metab Toxicol 2009; 5: 57-69.